戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 g the acid-catalyzed degradation reaction of erythromycin A.
2 was not detected in controls with or without erythromycin A.
3 acid stability of erythromycin B relative to erythromycin A.
4  to children as a suspension of the pro-drug erythromycin A 2'-ethyl succinate.
5 cursor-directed biosynthesis of 15-propargyl erythromycin A, a novel antibiotic that not only is as p
6 ae, as well as improved activity compared to erythromycin A against the inducibly MLS (macrolide, lin
7 -dihydro-9-acetamido-N-desmethyl-N-isopropyl erythromycin A analogues and related derivatives was gen
8                     The macrolide antibiotic erythromycin A and its semisynthetic analogues have been
9 zed hydrolysis of the 2'-ethyl succinates of erythromycins A and B.
10          Antibiotics such as doxycycline and erythromycin A are no exception.
11 ndustrial-scale production of the antibiotic erythromycin A, derivatives of which play a vital role i
12                  In the presence of cytomix, erythromycin A did not decrease NO, nitrite, iNOS protei
13 n analytical method for the determination of erythromycin A (ERY) residues in fish fillet was develop
14 e is much more stable than the corresponding erythromycin A ester, degrading nearly 40 times more slo
15 ribosome-binding antibiotics doxycycline and erythromycin, a finding that is not observed using antib
16                               The antibiotic erythromycin A is generally administered to children as
17                                              Erythromycin A is normally formulated for children as it
18    Three polyketide natural products, namely erythromycin A, lasalocid A, and iso-lasalocid A, were s
19 l drugs--norfloxacin, a fluoroquinolone, and erythromycin, a macrolide--proteins with single mutation
20                                              Erythromycin, a non-peptide motilin receptor agonist, in
21 epithelial cells, effects of doxycycline and erythromycin A on inducible NO synthase (iNOS) NO produc
22              We compared CYP3A metabolism of erythromycin (a Pgp substrate) using the erythromycin br
23                                              Erythromycin, a potent inhibitor of bacterial and mitoch
24  any link between this and the modulation of erythromycin A titre, which has been observed for S. ery
25                             At 0.5 microg/ml erythromycin, a total of eight strains (four Campylobact
26 e the extent of CYP3A-mediated metabolism of erythromycin, a widely used model substrate for CYP3A.
27 vel antibiotic that not only is as potent as erythromycin A with respect to its ability to inhibit ba